Explore the details of the Orphalan Sa V. Novitium Pharma Llc case under case number 1:23-cv-01079 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-01079
Filing Date
Sep 29, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Novitium Pharma LLC -
Orphalan SA -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US10988436B2
-US11072577B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Sep 29, 2023COMPLAINT FOR PATENT INFRINGEMENT filed against Novitium Pharma LLC ( Filing fee $ 402, receipt number ADEDC-4236555.) - filed by Orphalan SA. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(apk) (Entered: 09/29/2023)PACER Document
Sep 29, 2023Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orphalan SA. (apk) (Entered: 09/29/2023)PACER Document
Sep 29, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,988,436 ;11,072,577. (apk) (Entered: 09/29/2023)PACER Document
Sep 29, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/21/2023. Date of Expiration of Patent: 5/3/2039.Thirty Month Stay Deadline: 4/28/2029. (apk) (Entered: 09/29/2023)PACER Document
Sep 29, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 09/29/2023)PACER Document
Oct 3, 2023AMENDED DOCUMENT by Orphalan SA. Amendment to 5 Disclosure Statement Corrected. (Joyce, Alexandra) (Entered: 10/03/2023)PACER Document
Dec 1, 2023NOTICE of Voluntary Dismissal by Orphalan SA as to Defendant Novitium Pharma LLC (Silver, Daniel) (Entered: 12/01/2023)PACER Document
Dec 1, 2023Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 12/01/2023)PACER Document
Sep 29, 2023No Summons Issued. (apk)PACER Document
Oct 4, 2023Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb)PACER Document
Dec 1, 2023CASE CLOSED (ntl)PACER Document